GLP-1 Weight Loss Medication – 100% Online
Lose on average 15% - 20% of your current weight
Meet with nurse practitioners via telehealth video appointment
Medication shipped discreetly to your home
No insurance required - Starting at $297/mo (medication included)
FEATURED IN
No hidden fees – No insurance needed
Getting started is as easy as 1-2-3
See if you qualify
01
Call with provider
Meet with a licensed provider recieve your personalized plan
02
Receive your medication
Enjoy free and discreet shipping to your door and start slimming down
03
“Semaglutide marks a new era in
anti-obesity therapeutics”
Yale School of Medicine
“A new treatment for obesity”
Harvard Health
Publishing
HARVARD MEDICAL SCHOOL
No hidden fees – No insurance needed
SLIMR monthly plans
Semaglutide
Cost of medication included
$297
per month
15% Average Weight Loss
Compounded Semaglutide Medication*
Medication Discretely Delivered to Your Doorstep
Telehealth Visits With Nurse Practitioners
Dedicated Weight Loss Success Coach
*If you qualify and are prescribed medication, you will be charged $297/mo. High dose plans will cost $397/mo. Your clinician will make a treatment decision based on your medical history and overall health after the completion of a telehealth consultation. Medication costs vary based on the plan tailored to your specific needs. Without insurance, cash price for compounded semaglutide medication is $297/mo when filled via SLIMR’s platform.
Tirzepatide
Cost of medication included
$497
per month
20% Average Weight Loss
Compounded Tirzepatide Medication*
Medication Discretely Delivered to Your Doorstep
Telehealth Visits With Nurse Practitioners
Dedicated Weight Loss Success Coach
*If you qualify and are prescribed medication, you will be charged $497/mo for Low Dose, $597/mo. for Medium Dose and $697/mo. for High dose plans. Your clinician will make a treatment decision based on your medical history and overall health after the completion of a telehealth consultation. Medication costs vary based on the plan tailored to your specific needs. Without insurance, cash price for compounded Tirzepatide medication is $497/mo when filled via SLIMR’s platform.
What are GLP-1 medications and how do they work?
Now the cornerstone in contemporary weight management strategies, GLP-1s such as semaglutide (the active ingredient in Wegovy® and Ozempic®) and tirzepatide (the active ingredient in Mounjaro™ and Zepbound™) safely slow down the movement of food from the stomach into the small intestines, making you feel full faster and longer. Initially developed to control type 2 diabetes, these agonists are effective and safe in aiding weight loss.
Reduces Appetite
Curbs Cravings
Regulates Insulin
Ready to reach your weight loss goals?
How do I know which medication is right for me?
After carefully reviewing your medical history, your Slimr provider will select either semaglutide or tirzepatide with the proper weekly dosage, if approved. Through continued telehealth visits, your support team will help manage your weight loss safely and effectively.
What is the difference between semaglutide and tirzepatide?
The mechanisms of action are different from one another. Semaglutide is a GLP-1 receptor agonist and tirzepatide is a dual agonist, also targeting glucagon receptors. Multiple studies, including a recent 2023 clinical trial, found that tirzepatide resulted in more significant weight loss in subjects when compared to semaglutide.
What can I expect after signing up?
After completing the short medical questionnaire and submitting payment, you will meet with a licensed medical provider. Your provider will discuss the right treatment options for you and devise a personal plan prior to being prescribed any medication. Once prescribed, you will get your GLP-1 medication and can begin the program!
Backed by science, trusted by licensed medical providers
GLP-1 medications have been a game-changer for those seeking to lose weight effectively and have enabled me to provide more weight management options to patients. Our team at Slimr is focused on increasing access to those living with obesity to improve their health.
Emran Imami, MD, Chief Medical Director
